Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 15/20 | 0.64 |
| ▸ | CA9 | Q16790 | 13/20 | 0.64 |
| ▸ | CA1 | P00915 | 13/20 | 0.64 |
| ▸ | CA12 | O43570 | 12/20 | 0.64 |
| ▸ | CA5A | P35218 | 8/20 | 0.64 |
| ▸ | CA7 | P43166 | 8/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 8/20 | 0.64 |
| ▸ | CA6 | P23280 | 6/20 | 0.64 |
| ▸ | CA4 | P22748 | 6/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.64 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.64 |
| ▸ | CA3 | P07451 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| P-Toluenesulfonamide SCHEMBL28034266 | 0.89 | CA2 (0.78) | CA2CA9CA1CA12CA5A | |
| SCHEMBL202948 | 0.85 | CA2 (0.81) | CA2CA9CA1CA12CA5A | |
| SCHEMBL651902 | 0.85 | ALDH1A1 (0.71) | CA2CA9CA1CA12CA5A | |
| Sulfanilamide SCHEMBL29080914 | 0.79 | CA2 (0.85) | CA2CA9CA1CA12CA5A | |
| P-Chlorobenzenesulfonamide SCHEMBL196556 | 0.78 | CA2 (1.00) | CA2CA9CA1CA12CA5A | |
| SCHEMBL759946 | 0.78 | TSHR (0.62) | CA2CA9CA1CA12CA5A | |
| P-Chlorobenzenesulfonamide SCHEMBL31527679 | 0.78 | CA2 (1.00) | CA2CA9CA1CA12CA5A | |
| SCHEMBL10493509 | 0.77 | CA2 (0.68) | CA2CA9CA1CA12CA5A | |
| SCHEMBL9539098 | 0.77 | ALDH1A1 (0.60) | TDP1TSHRALDH1A1HSD17B10 | |
| SCHEMBL150162 | 0.77 | ALDH1A1 (0.60) | CA2CA9CA1CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170279145-A1 | MULTI-ACID POLYMERS FROM MULTIFUNCTIONAL AMINO ACIDS AND SULFONYL HALIDE PRECURSORS AND METHODS OF MAKING THE SAME | NISSAN MOTOR CO., LTD. (JP) | 2017-09-28 | — | — | US | claimed |
| EP-2142499-B1 | Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use for treating glaucoma | UNIMED PHARMA SPOL SRO (SK) | 2014-12-10 | — | — | EP | claimed |
| US-8193184-B2 | Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use | Unimed Pharma, SPOL, S.R.O. (SK) | 2012-06-05 | — | — | US | claimed |
| US-20100125076-A1 | SUBSTITUTED SULPHONAMIDES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND THEIR USE | UNIMED PHARMA, SPOL. S R.O. (SK) | 2010-05-20 | — | — | US | claimed |
| EP-2142499-A1 | SUBSITUTED SULPHONAMIDES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND THEIR USE | Unimed Pharma, Spol. S R.O. (SK) | 2010-01-13 | — | — | EP | claimed |
| WO-2008130332-A1 | SUBSITUTED SULPHONAMIDES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND THEIR USE | UNIMED PHARMA, SPOL. S R.O. (SK) | 2008-10-30 | — | — | WO | claimed |
| EP-3704090-B1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260135164-A1 | LITHIUM SECONDARY BATTERIES CAPABLE OF SELF-POISONING | PROLOGIUM TECHNOLOGY CO., LTD. (TW) | 2026-05-14 | — | — | US | disclosed |
| US-12606522-B2 | Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives | ORSOBIO, INC. (US) | 2026-04-21 | — | — | US | disclosed |
| EP-4668392-A1 | LITHIUM SECONDARY BATTERY CAPABLE OF SELF-POISONING | Prologium Technology Co., Ltd. (TW) | 2025-12-24 | — | — | EP | disclosed |
| EP-4668366-A1 | LITHIUM SECONDARY BATTERY CAPABLE OF SELF-POISONING | Prologium Technology Co., Ltd. (TW) | 2025-12-24 | — | — | EP | disclosed |
| EP-3728194-B1 | QUINOLINE SULFONAMIDE COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS | OTAGO INNOVATION LTD (NZ) | 2025-06-04 | — | — | EP | disclosed |
| CN-119998964-A | Self-poisoning lithium secondary battery | 辉能科技股份有限公司 | 2025-05-13 | — | — | CN | disclosed |
| EP-0673937-A1 | BICYCLIC HETEROCYCLIC SULFONAMIDE AND SULFONIC ESTER DERIVATIVES | Eisai Co., Ltd. (JP) | 1995-09-27 | — | — | EP | disclosed |
| EP-0512304-A1 | Silver halide color photographic elements containing a pyrazolo-triazole magenta coupler | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-11-11 | — | — | EP | disclosed |
| US-3984409-A | CEREBRAL VASODILATORS | PFIZER INC. (US) | 1976-10-05 | — | — | US | disclosed |
| US-3957797-A | CEREBRAL VASODILATORS | PFIZER INC. (US) | 1976-05-18 | — | — | US | disclosed |
| US-3932640-A | CEREBRAL VASODILATORS | PFIZER INC. (US) | 1976-01-13 | — | — | US | disclosed |
| US-3932647-A | CEREBRAL VASODILATORS | PFIZER INC. (US) | 1976-01-13 | — | — | US | disclosed |
| US-3932648-A | CEREBRAL VASODILATORS | PFIZER INC. (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260135164-A1 | LITHIUM SECONDARY BATTERIES CAPABLE OF SELF-POISONING | L3MBTL3, HAO2, LDHB | CA2 14/4885CA9 28/4885CA1 12/4885 |
| US-20100125076-A1 | SUBSTITUTED SULPHONAMIDES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION COMPRISING THEREOF AND THEIR USE | ARSA, SMS, SULT1E1 | CA2 36/4885CA9 70/4885CA1 653/4885 |
| US-12606522-B2 | Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives | NR3C2, NR5A1, SRD5A2 | CA2 3086/4885CA9 1910/4885CA1 3778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.